Literature DB >> 10206659

Human glucosamine-6-phosphate isomerase, a homologue of hamster oscillin, does not appear to be involved in Ca2+ release in mammalian oocytes.

Y M Wolny1, R A Fissore, H Wu, M M Reis, L T Colombero, B Ergün, Z Rosenwaks, G D Palermo.   

Abstract

Injections of cytosolic preparations from mammalian sperm into oocytes have been shown to trigger calcium [Ca2+]i oscillations and initiate activation of development. Recently, a protein isolated from hamster sperm has been suggested to be involved in the generation of these oscillations and it was named "oscillin." The human homologue of hamster oscillin is glucosamine 6-phosphate isomerase (GPI, EC no. 5.3.1.10), an enzyme so far described to be involved in hexose phosphate metabolism. To assess the role of GPI on Ca2+ signaling, a human recombinant protein was generated in a prokaryotic system and injected into fura-2-dextran-loaded metaphase II (MII) mouse oocytes. Injection of recombinant GPI failed to induce Ca2+ responses in 12/12 injected MII oocytes despite the fact that the recombinant GPI was active as assessed by an enzymatic assay. Injection of buffer (0/6 oocytes) or fructose-6-phosphate, a product of GPI enzymatic reaction (0/5 oocytes), also failed to initiate Ca2+ responses. Conversely, injections of sperm cytosolic factor induced [Ca2+]i oscillations in all 17/17 oocytes. In addition, injection of recombinant GPI or GPI mRNA failed to induce parthenogenetic activation (0/30 oocytes). Immunofluorescence studies using an anti-GPI polyclonal antibody (GK) resulted in localization of GPI to the sperm's equatorial region. Incubation of the GK antibody with sperm extracts failed to block the [Ca2+]i responses induced by these extracts. Moreover, near complete depletion of GPI from sperm fractions by immunoprecipitation did not impair the ability of these fractions to induce [Ca2+]i oscillations. In summary, our results support the role of a sperm cytosolic component(s) in the generation of [Ca2+]i oscillations during mammalian fertilization, although a protein other than GPI/oscillin is likely to be the active calcium releasing factor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10206659     DOI: 10.1002/(SICI)1098-2795(199903)52:3<277::AID-MRD5>3.0.CO;2-0

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  7 in total

Review 1.  Calcium at fertilization and in early development.

Authors:  Michael Whitaker
Journal:  Physiol Rev       Date:  2006-01       Impact factor: 37.312

Review 2.  The eggstraordinary story of how life begins.

Authors:  John Parrington; Christophe Arnoult; Rafael A Fissore
Journal:  Mol Reprod Dev       Date:  2018-11-30       Impact factor: 2.609

Review 3.  Understanding fertilization through intracytoplasmic sperm injection (ICSI).

Authors:  Queenie V Neri; Bora Lee; Zev Rosenwaks; Khaled Machaca; Gianpiero D Palermo
Journal:  Cell Calcium       Date:  2013-11-15       Impact factor: 6.817

4.  The testicular and epididymal expression profile of PLCζ in mouse and human does not support its role as a sperm-borne oocyte activating factor.

Authors:  Mahmoud Aarabi; Yang Yu; Wei Xu; Man Y Tse; Stephen C Pang; Young-Joo Yi; Peter Sutovsky; Richard Oko
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

5.  Sperm-borne phospholipase C zeta-1 ensures monospermic fertilization in mice.

Authors:  Kaori Nozawa; Yuhkoh Satouh; Takao Fujimoto; Asami Oji; Masahito Ikawa
Journal:  Sci Rep       Date:  2018-01-22       Impact factor: 4.379

Review 6.  Sperm-oocyte interplay: an overview of spermatozoon's role in oocyte activation and current perspectives in diagnosis and fertility treatment.

Authors:  Mohammad Ishraq Zafar; Shi Lu; Honggang Li
Journal:  Cell Biosci       Date:  2021-01-06       Impact factor: 7.133

Review 7.  Intracytoplasmic sperm injection: state of the art in humans.

Authors:  G D Palermo; C L O'Neill; S Chow; S Cheung; A Parrella; N Pereira; Z Rosenwaks
Journal:  Reproduction       Date:  2017-11-20       Impact factor: 3.906

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.